MedPath

"New Perspectives of Adaptation to NIV in ALS"

Not Applicable
Completed
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
Other: Adaptation and training to Non Invasive Ventilation (NIV)
Registration Number
NCT02537132
Lead Sponsor
Fondazione Don Carlo Gnocchi Onlus
Brief Summary

The purpose of this study is to demonstrate that the adaptation to the Non Invasive Ventilation (NIV) at home is not worse when compared with an adaptation performed in inpatient settings.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • ALS diagnosis according to the criteria of El Escorial;
  • Clinical indication to NIV (nocturnal hypoventilation and respiratory muscle weakness confirmed according to the criteria normally accepted);
  • No respiratory infection within 3 months
  • Severe disability (ALS-FRS <31);
  • Age > 18 years;
  • The voluntary participation to the Study.
Exclusion Criteria

-- Previous episodes of pneumothorax;

  • Comorbid cardiac and / or renal important
  • Severe cognitive impairment;
  • Refusal of the patient at the time of Informed Consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Home GroupAdaptation and training to Non Invasive Ventilation (NIV)Adaptation and training to Non Invasive Ventilation (NIV) (not less than five sessions), at home
Outpatient GroupAdaptation and training to Non Invasive Ventilation (NIV)Adaptation and training to Non Invasive Ventilation (NIV) (not less than five sessions), at the outpatient clinic
Primary Outcome Measures
NameTimeMethod
Change from baseline in adherence NIV in ALS patients at baseline, 2 and 4 months as measured by monthly means and standard deviations of hours of use of Non Invasive Ventilation (NIV)Baseline + after 2 and 4 months from the recruitment

The primary outcome the time of adherence to NIV defined as actual use of NIV for not less than 150 hours / month.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Michele Vitacca

🇮🇹

Lumezzane, Brescia, Italy

Paolo Banfi

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath